The Profiling and Role of miRNAs in Diabetes Mellitus

Michael Kim1, Xiaokan Zhang1

  • 1Department of Medicine, Division of Cardiology, Columbia University Medical Center, New York, NY, USA.

Journal of Diabetes and Clinical Research
|May 21, 2020
PubMed

Insights

MicroRNAs (miRNAs) show altered expression in diabetes mellitus (DM) progression, serving as potential biomarkers. This review highlights their regulatory roles and functional impact in DM pathogenesis.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Genetics

Background:

  • Diabetes mellitus (DM) is a significant global metabolic health challenge.
  • MicroRNAs (miRNAs) are key post-transcriptional gene regulators.
  • Altered miRNA expression is increasingly linked to DM pathology.

Purpose of the Study:

  • To review recent investigations on miRNA profiles as novel DM biomarkers.
  • To highlight the complex regulatory effects and functional roles of miRNAs in DM.
  • To synthesize findings from clinical studies and animal models.

Main Methods:

  • Literature review of recent scientific investigations.
  • Analysis of studies focusing on miRNA expression signatures in DM.
  • Examination of clinical and animal model data.

Main Results:

  • Specific miRNA expression signatures are altered during DM progression.
  • miRNAs demonstrate potential as diagnostic and prognostic biomarkers for DM.
  • Complex regulatory networks involving miRNAs are crucial in DM pathogenesis.

Conclusions:

  • miRNAs represent promising novel biomarkers for diabetes mellitus.
  • Understanding miRNA functions is vital for elucidating DM mechanisms.
  • Further research into miRNA-based diagnostics and therapeutics is warranted.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K